Panasonic Accuses CardioNexus Of Obscuring Software's Value

Law360, New York (July 16, 2012, 5:35 PM EDT) -- Panasonic Corp. on Sunday accused CardioNexus Corp. and two of its executives of misleading it into buying a minority stake in the medical device manufacturer by misrepresenting the value of and the status of regulatory approval for key software.

The tech giant says it invested $6.5 million in CardioNexus in October 2010 to help progress a new ultrasound diagnostic device called AIDA — which Panasonic had initially and independently developed — that is designed to allow for early detection and prevention of heart disease.

CardioNexus provided...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.